BIBS-868

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBIBS-868
Drug Alias Nameantihypertensives (Boehringer Ingelheim)BIBS-868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor X inhibitorsFactor IIa inhibitors
TargetsCoagulation factor XProthrombin
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim Pharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A